🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📣 Updated ESMO #ClinicalPracticeGuideline on #localised #rectalcancer: tailored intensification/de-intensification, complex radiological factors, #biomarkers & organ-preserving Tx options. #ESMOGuidelines 🔗 ow.ly/q2VV50VWTAU

Findings from a phase 2 study show that neoadjuvant PD-1 blockade w/ dostarlimab led to sustained clinical complete response in a substantial proportion of pts w/ early-stage #MismatchRepairDeficient solid tumours Read the news in the #ESMODailyReporter🔗 ow.ly/ZZuC50VWUBI

👉 Stay up to date with the latest evidence-based recommendations from the #ESMOGuidelines for the treatment of metastatic #breastcancer to optimise patient outcomes. Join this live discussion and submit your questions 🔗 ow.ly/qwpi50VX2bo

Interested in the latest developments in #BreastCancer? Check out the most recent articles from #ESMOBreast25 in the #ESMODailyReporter and stay up-to-date with the cutting-edge developments in #oncology 🔗 ow.ly/F82v50VXG4P

We started this Programme almost 10 years ago and it has been a success since then! Don't miss this unique opportunity to strength your skills in leadership and communication. @Teresa Amaral ESMO - Eur. Oncology #career #leadership #communication

Cannot stress enough this is a huge opportunity and a great experience ESMO - Eur. Oncology

👉 Prof. Jeanne Tie, Scientific Committee member, invites you to join fellow researchers and clinicians in Barcelona for ESMO GI 2025, where the brightest innovations in gastrointestinal cancer research spark new discussions. #ESMOGI25 🔗 ow.ly/SOBW50VYG7g

🤖 Discover the new ESMO AI & Digital Oncology Hub, a virtual place for medical oncologists seeking content, expert perspectives, practical resources & guidance on AI and digital technologies in oncology 🔗 ow.ly/y5t150W05jj #AIOncology #HealthAI #ESMOAI25

#ESMO4Carers: Why does #ImpostorSyndrome affect #oncologists? ESMO #Resilience Task Force Workshop participants highlight initiatives fostering the #wellbeing of the #OncologyWorkforce. Susana Banerjee Jon Lim, MRCP PhD Enes Erul MD

Two major clinical trials are setting new standards in the treatment of #AnalCancer and #RectalCancer showing promising outcomes w/ reduced-dose chemoradiotherapy & non-surgical strategies. Read the news in the #ESMODailyReporter 🔗 ow.ly/7n9s50W1nFk #LowerGICancer

📣Only a few days left! Submit your #MAP2025 abstract by 10 June, 21:00 CEST. Paris hosts a global stage for precision oncology – AI, immunotherapy, cancer evolution, and more. Young oncologists & scientists under 40: apply for a MAP Merit Travel Grant 🔗 ow.ly/cVFp50W05ZO

#ESMOMembers – Help shape ESMO’s leadership and future direction! Cast your vote for the ESMO Directors and the Nomination Committee Chair and members. 🗳️Voting closes at 12:00 (noon) CEST on Tuesday, 10 June. 🔗 ow.ly/UAXn50W3SLF

On #WorldEnvironmentDay, ESMO stands w/ the global community to #BeatPlasticPollution. #Microplastics are found in organs and tumours. More research needed to understand their role in cancer development Pawel Sobczuk 🔗 ow.ly/Q8xT50W3VCP #ESMODailyReporter